CMS has issued a proposed rule that would result in a net increase of 2.6% to the Medicare inpatient prospective payment system rate for fiscal year 2025, a raise that hospital trade groups say doesn’t go far enough.

A recent investigation from KFF Health News about payments to members of an FDA panel evaluating an Abbott Laboratories cardiac device is raising eyebrows.

The Private Equity Stakeholder Project’s new State Risk Index is calculated based on 16 unique indicators. 

CMS must ensure transparency, clarity and predictability by providing detailed guidance on comparator drug selection and the evaluation of evidence, according to a group of D.C.-based health policy researchers.

U.S. Senator Elizabeth Warren, an outspoken critic of private equity's influence, praised the group's efforts. "Together, we’re taking on this trillion-dollar, behemoth industry that’s hurting working people and sucking money out of the rest of the economy," she said. 

"This was an unneeded burden, which was solely adding to the administrative hassles of medicine," said American Society of Nuclear Cardiology President Larry Phillips.

The American College of Radiology praised the hearing as a potential first step to address inadequate reimbursement levels under the federal payment program. 

The American Medical Association has sent its study to thousands of members of the specialty but only received seven responses, ACR says.